XALKORI® (crizotinib) For ALK+ or ROS1+ mNSCLC Treatment
Learn about Rx XALKORI® (crizotinib) for treatment of ALK+ or ROS1+ non-small cell lung cancer that has spread to other parts of the body. See risks & benefits.
About XALKORI® (crizotinib) | Safety Info
Learn about XALKORI® (crizotinib), an Rx option for ALK+ or ROS1+ metastatic non-small cell lung cancer (mNSCLC). See risks & benefits.
XALKORI® (crizotinib) is a prescription medicine used to treat people with non-small cell lung cancer (NSCLC) that has spread to other parts of the body and is caused by a defect in either a gene called ALK (anaplastic lymphoma kinase) or a gene called ROS1.
About Non-Small <b>Cell Lung Cancer</b> - XALKORI
Learn about non-small cell lung cancer (NSCLC) and how genetics is changing the way we look at the disease on the official XALKORI® site. See risks & benefits.
XALKORI® (crizotinib) Rx Resources | Safety Info
Learn about personalized patient support & find downloadable resources for XALKORI®, an Rx option for ALK+ or ROS1+ mNSCLC. See risks & benefits.
Filling XALKORI® (crizotinib) Rx | Safety Info
Find information on filling a XALKORI® (crizotinib) prescription through certain specialty pharmacies.
Register for XALKORI® (crizotinib) Support | Safety Info
Register to receive additional resources, including a patient starter kit designed to support patients who are taking XALKORI®. See risks & benefits.
xalkori (crizotinib) is a prescription medicine used to treat people with non-small cell lung cancer (NSCLC) that has spread to other parts of the body and is caused by a defect in either a gene called ALK (anaplastic lymphoma kinase) or a gene called ROS1.
Pfizer-Pledge-Warranty-Program - XALKORI
XALKORI is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC) that has spread to other parts of the body and is caused by a defect in either a gene called ALK (anaplastic lymphoma kinase) or a gene called ROS1. It is not known if XALKORI is safe and effective in children with NSCLC.
TO BE COMPLETED BY PATIENT 2 OF 7 Be sure your HCP faxes the completed form to 1-877-736-6506 or mail to: Pfizer Oncology Together, PO Box 220366, Charlotte, NC 28222-0366. For questions, please call 1-877-744-5675, MondayFriday, 8 AM 8 PM ET. For details about how we collect and use personal information, including applicable U.S. state privacy